https://www.selleckchem.com/pr....oducts/ly2874455.htm
Minority patients are under-screened for chronic hepatitis C (CHC) in the USA, and limited data exist for minority patients with advanced fibrosis. In this cross-sectional study, CHC patients who were prescribed direct-acting antiviral agents were divided into White patients and minority patient groups. Primary measurements were the mean fibrosis scores and percentages of patients with stage III-IV fibrosis (late presenters) for the two groups. Among the 1421 patients with self-reported ethnicity, 697 were White patients, and 724 were
Like
Comment
Share
